ArticlePLoS medicine2026
Health disparities in transitions between kidney replacement therapy modalities and mortality in England: A multistate model using UK Renal Registry data.
Article in PLoS medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundWhile ethnic and deprivation-related disparities in kidney replacement therapy (KRT) initiation are well established, their impact on transitions between treatment modalities and mortality over the course of kidney failure remains poorly understood. This study aimed to examine the association between ethnicity and area-level deprivation and the rates of transition between treatment modalities and death across the patient life course on KRT. METHODS AND
findingsWe used a parametric multistate model to analyse UK Renal Registry data from 93,451 patients initiating KRT in England between 2005 and 2020 with a median follow-up of 1,497 days [IQR: 640-2,841] (4.1 years [IQR: 1.75,7.8]). We estimated transition-specific hazard rates and probabilities between peritoneal dialysis (PD), home haemodialysis (HHD), in-centre haemodialysis (ICHD), transplantation, and death using Weibull proportional hazard models. Ethnicity and area-level deprivation (measured by quintiles of the Index of Multiple Deprivation [IMD]) were included as covariates of primary interest, with models additionally adjusted for sex, age and diabetes mellitus as the primary kidney disease (PKD). Compared with White patients, Asian patients had lower transition rates from ICHD to PD (hazard ratio [HR]: 0.68, 95% confidence interval [CI] [0.51,0.91]), and from PD to ICHD (HR 0.85, 95% CI [0.78,0.92]), but a higher rate of returning to ICHD after transplantation (HR 1.12, 95% CI [1.01,1.24]). Black patients also had lower transition rates from ICHD to PD (HR 0.64, 95% CI [0.47,0.88]) and to HHD (HR 0.47, 95% CI [0.37,0.61]), but higher rates of transition from PD to ICHD (HR 1.16, 95% CI [1.01,1.33]) and from transplantation to ICHD (HR 1.73, 95% CI [1.44,2.08]). Patients living in the most deprived areas had lower transition rates from ICHD to PD (HR 0.63, 95% CI [0.56,0.70]), to HHD (HR 0.49, 95% CI [0.38,0.64]), and to transplantation (HR 0.57, 95% CI [0.52,0.64]), and higher rates from transplantation to ICHD (HR 1.63, 95% CI [1.43,1.85]) and to death (HR 1.53, 95% CI [1.33,1.76]), compared with those from the least deprived areas. A limitation of our study is that, apart from diabetes mellitus as the PKD, comorbidities were not included in the analysis due to incomplete reporting in the UK Renal Registry. This should be considered when interpreting the observed disparities, particularly those related to area-level deprivation.
conclusionsThese findings highlight persistent inequalities throughout the KRT pathway. The multistate modelling framework applied in this study offers a foundation for future research to design and evaluate interventions that improve equity and patient outcomes in kidney care.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.